Active Ingredient(s): Celecoxib + Tramadol Hydrochloride
FDA Approved: * October 15, 2021
Pharm Company: * ESTEVE
Category: Pain Relief

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Seglentis Overview

Celecoxib/tramadol sold under the brand name Seglentis, is a fixed-dose combination of the anti-inflammatory celecoxib and the opioid tramadol used for the management and treatment of pain.[1] Developed by Spanish pharmaceutical company Esteve, it was approved for medical use in the United States in October 2021.[1][2][3] References .mw-parser-output .reflist{font-size:90%;margin-bottom:0.5em;list-style-type:decimal}.mw-parser...

Read more Seglentis Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Seglentis Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Celecoxib + Tramadol Hydrochloride
  • Tablet: 56mg + 44mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Drugs with one or more similar ingredients: (8 results)